MIT researchers have developed a new silver nanoparticle-based paper test that can quickly detect dengue, yellow fever and Ebola, reports Vicki Davison for Scientific American. In addition to the paper test, the researchers are also working on developing a mobile application to ease diagnosis.
MIT researchers have found that few health care studies use the random assignment method, considered to be the gold standard in scientific research, reports U.S. News & World Report. The researchers “analyzed hundreds of studies about improving health care and found that only 18 percent of those conducted in the United States used the random assignment method.”
A new study by Prof. Amy Finkelstein found that few health care system studies used the random assignment method, considered the gold standard for scientific research, reports Sabrina Tavernise for The New York Times. “The beauty of randomization is that it allows you to be sure of the cause,” says Finkelstein of the importance of using the method.
Michelle Roberts reports for BBC News on a new, “smart insulin” being developed by MIT researchers that switches on when blood sugar rises. The engineered insulin could make it easier for those suffering from diabetes to manage the disease, Roberts explains.
Joseph Flaherty of Wired writes about “Flowers,” a print created by postdoctoral fellow Tal Danino and MIT visiting artist Vik Muniz to educate people about the importance of vaccinations. Danino hopes to be able to apply the technique developed for creating the print, which contains real cancer and virus cells, to control the behaviors of specific cells and bacteria.
In an article for MedPage Today, Shara Yurkiewicz writes about a new MIT study showing that high demand for desirable medical residencies keeps salaries low. Prof. Nikhil Agarwal explains that, “even if salary negotiation was allowed, the salaries of medical residents would be quite low compared with physician assistants or nurse practitioners.”
Curt Nickisch of WBUR reports that MIT, Harvard, MGH and The Boston Globe are joining forces for HUBweek, a weeklong festival focused on innovation to be held in the fall of 2015. “MIT plans to host a huge gathering called SOLVE to tackle with some of the world’s most perplexing problems,” reports Nickisch.
Matt Murphy writes for WBUR about Solve, an event MIT will host next fall as part of the HUBweek innovation festival. The event will focus on “research and problem-solving exercises” aimed at four areas: education, health care, manufacturing, and environmental sustainability and energy.
Yiqing Shao of Boston Magazine reports on HUBweek, a new innovation festival that will be co-hosted by MIT, The Boston Globe, Harvard and MGH. “By uniting so many of the region’s leading institutions, HUBweek itself embodies the open, collaborative spirit that has helped make Greater Boston and Cambridge a hotbed of innovation and new ideas,” said MIT President L. Rafael Reif.
Boston Globe reporter Michael Levenson writes about HUBweek, an “innovation-themed festival” that aims to showcase Boston. As part of HUBweek, MIT will host “‘Solve’ to brainstorm solutions to problems in education, energy, the environment, manufacturing, and infrastructure.”
“If the festival helps experts in Greater Boston make new connections across disciplines and across institutions — and find common interests and opportunities for collaboration with people around the world — the region as a whole can only benefit,” writes The Boston Globe Editorial Board of HUBweek, which will be co-hosted by MIT.
Dr. Tara Swart speaks with Charlotte Clarke of The Financial Times about her work and what inspired her to switch from working in medicine to business. “My mission is to disseminate simple, pragmatic neuroscience-based messages that change the way people work and that translate to tangible financial improvements in business,” says Swart of her work.
WBUR’s Deborah Becker and Lynn Jolicoeur report on the new MIT-MGH partnership aimed at developing better tools to treat disease. Prof. Arup Chakraborty hopes the collaboration will allow researchers to take risks. “Safe ideas are often not the transformative ones,” he says.
Nature highlights the top science news of the week, including the new interdisciplinary center at MIT aimed at examining the microbiome. “The center will initially focus on inflammatory bowel disease, but organizers hope to eventually broaden the scope to diseases such as multiple sclerosis, arthritis and autism,” Nature reports.
In a piece for The Atlantic, Sarah Laskow writes about how MIT researchers have developed a new drug-delivery capsule that could serve as an alternative to injections. The new drug capsule would make it possible to “deliver drugs that would otherwise break down in the digestive tract.”